←
Bioanalysis Zone12,917 posts
Bioanalysis Zone avatar

Bioanalysis Zone

@BioanalysisZone

Bioanalysis Zone, part of Taylor & Francis, is the definitive resource for the modern bioanalyst, featuring the latest news, research, webinars, eBooks and more

◷ Joined August 2011▧ 6,846 Photos and videos
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·3h

❓ Struggling with #biomarker assay sensitivity? Working with novel targets or exploratory endpoints?  Elizabeth Hickford from @Resolian_ explains how understanding your context of use from the very first conversation can make or break your bioanalytical strategy. Whether you're measuring low-abundance biomarkers in tissue extracts or developing assays for free vs. drug-bound targets, this interview is packed with practical guidance.  Don't miss it >>> hubs.ly/Q04zg5LP0

Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·5h

Some good news for flu season! Molecular Designs have just received FDA 510(k) clearance for their multiplex real-time RT-PCR test, which can detect and differentiate between influenza A, influenza B and RSV in nasal swab samples. Read the full story ➡️Flu and RSV test earns FDA 510(k) clearance - Bioanalysis Zone (eu1.hubs.ly/H0zYPNG0)

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·21h

Yourgene Health has won Australian regulatory clearance for its Yourgene® Insight DPYD assay, allowing Southern Cross Diagnostics – a distributor of diagnostics and life science products – to supply the test to clinical labs to help personalize chemotherapy and protect cancer patients from severe drug toxicity. Read the full story: Yourgene® Insight DPYD assay receives Australian approval - Bioanalysis Zone (eu1.hubs.ly/H0zZ9m50)

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 17

Interested in biomarker validation strategy? Learn the implications of the latest guidance from the US Food and Drug Administration in this Perspective from @Resolian_. You’ll also get insight into the role of ICH M10 as the foundation for this guidance, as well as #biomarker assay development. Download the #Perspective today >>> hubs.ly/Q04zq12G0

Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 17

“High-quality bioanalytical data creates value only when its context is understood, enabling informed decisions that ultimately support successful drug development.”  Explore the bioanalytical challenges and strategic considerations involved in supporting antibody-drug conjugate (ADC) development programs from a CRO laboratory perspective.  Dr Wibke Lembke shares her expertise in our latest #interview, in collaboration with @GyrosProteinTec >>> hubs.ly/Q04z-PMl0

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 17

It's day 1 of EBF 2026 and we're giving away 150 Bioanalysis Glossaries! Head to booth B22 to pick up your copy 📖 Plus, three lucky winners will take home a BioA-themed LEGO set... GO GO GO

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 16

Trick question: which LBA format for ADC analysis works best?   The question is not which platform is best in principle. The question is which platform gives you the highest probability of passing validation on the first attempt, transferring to your CRO without a re-optimization cycle, and generating data your regulatory submission will not need to defend.  We've made things easy for you and created a guide on ADC-specific regulatory considerations for ligand binding assays.  Download now for free >>> hubs.ly/Q04z-PSC0

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 16

🎙️In this interview Chris Beaver (Global Head of Clinical Regulated Bioanalysis at Daiichi Sankyo, Inc.) explores the state of regulated bioanalysis, sharing insights on ICH M10, cross-validation strategies and the regulatory gaps around cell and gene therapies, ADCs and AI-driven analytics. The conversation closes with a look at upcoming regulatory changes that bioanalysts should be aware of. Read the full Q&A: A conversation on the state of regulated bioanalysis - Bioanalysis Zone (eu1.hubs.ly/H0zW49X0)

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 13

Next week is the 19th European Bioanalysis Forum and we're giving away 150 Glossaries! Head over to booth B22 to pick up your copy, plus enter our prize draw for a chance to win a BioA-themed LEGO set! Don't miss out!

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 13

ADC bioanalysis is typically performed in serum or plasma. Still, matrix interference remains a significant challenge due to the molecule’s structural complexity and the presence of circulating drug-related species.   How does matrix interference manifest in LBA development for ADCs, and what strategies have proven most effective in the laboratory?  Dr Wibke Lembke discusses practical approaches to managing matrix interference and key lessons learned from supporting multiple ADC programs in our latest interview!  Learn more here >>> hubs.ly/Q04z-PPj0

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 12

From proteins and peptides to nucleic acids and metabolites across diverse biological matrices, developing fit-for-purpose biomarker assays comes with unique challenges.  This Spotlight brings together CRO and Sponsor perspectives to help you navigate method development, validation strategies and achieving alignment. Explore all our Spotlight resources here >>> hubs.ly/Q04zg2JJ0

Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 11

A research team at the University of Illinois Urbana-Champaign’s Grainger College of Engineering has developed a testing approach that can identify Zika and hepatitis C infections within hours, without requiring sophisticated laboratory equipment, and with the aim to bring viral diagnosis closer to patients in areas with limited healthcare infrastructure. The rapid test uses heat to dry the blood sample prior to RNA amplification and fluorescence detection with two nifty tools: a handheld reader and a portable heater. Read more: A portable test for Zika and hepatitis C - Bioanalysis Zone (hubs.ly/Q04DZCv_0)

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 11

Out of our outstanding panel of finalists, we are delighted to announce Giorgi Kobidze (Marche Polytechnic University) as the 2026 winner of the Bioanalysis Rising Star Award! 🎉   Learn more here: Bioanalysis Zone announces winner of Rising Star Award 2026 - Bioanalysis Zone (hubs.ly/Q04xXFLs0)

Post attachment
Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 10

Learn more about robust Activin E measurements that can provide a more biologically meaningful assessment of target engagement and biological activity. Read the #CaseStudy, in partnership with @Resolian_ here >>>  hubs.ly/Q04zpZ_m0

Bioanalysis Zone avatar
Bioanalysis Zone@BioanalysisZone·Nov 10

There's just 1 week to go until the European Bioanalysis Forum 2026! We can't wait to catch up in Barcelona, so make sure to stop by our booth (B22) to chat about the journal, the Zone and everything in between!

Post attachment